• Something wrong with this record ?

Effect of angiotensin-converting enzyme tag single nucleotide polymorphisms on the outcome of patients with traumatic brain injury

E. Dardiotis, K. Paterakis, V. Siokas, G. Tsivgoulis, M. Dardioti, S. Grigoriadis, C. Simeonidou, A. Komnos, E. Kapsalaki, K. Fountas, GM. Hadjigeorgiou,

. 2015 ; 25 (10) : 485-90.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: Genetic variants appear to influence, at least to some degree, the extent of brain injury and the clinical outcome of patients who have sustained a traumatic brain injury (TBI). Angiotensin-converting enzyme (ACE) is a zinc metallopeptidase that is implicated in the regulation of blood pressure and cerebral circulation. ACE gene polymorphisms were found to regulate serum ACE enzyme activity. OBJECTIVE: The present study aimed to investigate possible influence of ACE gene region variants on patients' outcome after TBI. PATIENTS AND METHODS: In total, 363 TBI patients prospectively enrolled in the study were genotyped for five tag single nucleotide polymorphisms (SNPs) across the ACE gene. Using logistic regression analyses, tag SNPs and their constructed haplotypes were tested for associations with 6-month Glasgow Outcome Scale scores, after adjustment for age, sex, Glasgow Coma Scale scores at admission, and the presence of a hemorrhagic event in the initial computed tomography scan. RESULTS: Significant effects on TBI outcome were found for three neighboring tag SNPs in the codominant (genotypic) model of inheritance [rs4461142: odds ratio (OR) 0.26, 95% confidence interval (CI) 0.12-0.57, P = 0.0001; rs7221780: OR 2.67, 95% CI 1.25-5.72, P = 0.0003; and rs8066276: OR 3.82, 95% CI 1.80-8.13, P = 0.0002; for the heterozygous variants compared with the common alleles]. None of the constructed common tag SNPs haplotypes was associated with TBI outcome. CONCLUSION: The present study provides evidence of the possible influence of genetic variations in a specific region of the ACE gene on the outcome of TBI patients. This association may have pharmacogenetic implications in identifying those TBI patients who may benefit from ACE inhibition.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16020530
003      
CZ-PrNML
005      
20160913103457.0
007      
ta
008      
160722s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/FPC.0000000000000161 $2 doi
024    7_
$a 10.1097/FPC.0000000000000161 $2 doi
035    __
$a (PubMed)26181640
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Dardiotis, Efthimios $u aLaboratory of Neurogenetics, Department of Neurology bDepartment of Neurosurgery, Faculty of Medicine, University Hospital of Larissa, University of Thessaly cIntensive Care Unit, General Hospital of Larissa dDepartment of Radiology, School of Medicine, University of Thessaly, Larissa eSecond Department of Neurology, School of Medicine, 'Attikon' University Hospital, University of Athens, Athens fSecond Department of Neurosurgery, Hippokration University Hospital gDepartment of Physiology, Aristotle University of Thessaloniki, Thessaloniki, Greece hInternational Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
245    10
$a Effect of angiotensin-converting enzyme tag single nucleotide polymorphisms on the outcome of patients with traumatic brain injury / $c E. Dardiotis, K. Paterakis, V. Siokas, G. Tsivgoulis, M. Dardioti, S. Grigoriadis, C. Simeonidou, A. Komnos, E. Kapsalaki, K. Fountas, GM. Hadjigeorgiou,
520    9_
$a BACKGROUND: Genetic variants appear to influence, at least to some degree, the extent of brain injury and the clinical outcome of patients who have sustained a traumatic brain injury (TBI). Angiotensin-converting enzyme (ACE) is a zinc metallopeptidase that is implicated in the regulation of blood pressure and cerebral circulation. ACE gene polymorphisms were found to regulate serum ACE enzyme activity. OBJECTIVE: The present study aimed to investigate possible influence of ACE gene region variants on patients' outcome after TBI. PATIENTS AND METHODS: In total, 363 TBI patients prospectively enrolled in the study were genotyped for five tag single nucleotide polymorphisms (SNPs) across the ACE gene. Using logistic regression analyses, tag SNPs and their constructed haplotypes were tested for associations with 6-month Glasgow Outcome Scale scores, after adjustment for age, sex, Glasgow Coma Scale scores at admission, and the presence of a hemorrhagic event in the initial computed tomography scan. RESULTS: Significant effects on TBI outcome were found for three neighboring tag SNPs in the codominant (genotypic) model of inheritance [rs4461142: odds ratio (OR) 0.26, 95% confidence interval (CI) 0.12-0.57, P = 0.0001; rs7221780: OR 2.67, 95% CI 1.25-5.72, P = 0.0003; and rs8066276: OR 3.82, 95% CI 1.80-8.13, P = 0.0002; for the heterozygous variants compared with the common alleles]. None of the constructed common tag SNPs haplotypes was associated with TBI outcome. CONCLUSION: The present study provides evidence of the possible influence of genetic variations in a specific region of the ACE gene on the outcome of TBI patients. This association may have pharmacogenetic implications in identifying those TBI patients who may benefit from ACE inhibition.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a alely $7 D000483
650    _2
$a poranění mozku $x genetika $7 D001930
650    _2
$a demografie $7 D003710
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a frekvence genu $x genetika $7 D005787
650    _2
$a genetické lokusy $7 D056426
650    _2
$a Glasgowská stupnice kómat $7 D015600
650    _2
$a haplotypy $7 D006239
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multivariační analýza $7 D015999
650    _2
$a angiotensin konvertující enzym $x genetika $7 D007703
650    _2
$a jednonukleotidový polymorfismus $x genetika $7 D020641
650    _2
$a výsledek terapie $7 D016896
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Paterakis, Konstantinos
700    1_
$a Siokas, Vasileios
700    1_
$a Tsivgoulis, Georgios
700    1_
$a Dardioti, Maria
700    1_
$a Grigoriadis, Savas
700    1_
$a Simeonidou, Constantina
700    1_
$a Komnos, Apostolos
700    1_
$a Kapsalaki, Eftychia
700    1_
$a Fountas, Kostas
700    1_
$a Hadjigeorgiou, Georgios M
773    0_
$w MED00189565 $t Pharmacogenetics and genomics $x 1744-6880 $g Roč. 25, č. 10 (2015), s. 485-90
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26181640 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20160913103816 $b ABA008
999    __
$a ok $b bmc $g 1155200 $s 945058
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 25 $c 10 $d 485-90 $i 1744-6880 $m Pharmacogenetics and genomics $n Pharmacogenet Genomics $x MED00189565
LZP    __
$a Pubmed-20160722

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...